Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin as Adjuvant to Treatment of Pulmonary Tuberculosis
NCT04721795Phase 3Completed
- Sponsor
- Obafemi Awolowo University Teaching Hospitals Complex
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of atorvastatin in pulmonary tuberculosis (TB), sponsored by Obafemi Awolowo University Teaching Hospitals Complex. Started Jan 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04721795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04721795.